Similar Items: Comparative evaluation of the activity of novel β-lactam antibiotics against difficult-to-treat Pseudomonas aeruginosa clinical isolates
- Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens
- P74 Addition of probenecid to β-lactam antibiotics in the treatment of skin and soft tissue infections: a systematic review
- Comment on: An improved algorithm to screen for carbapenemase production in Pseudomonas aeruginosa
- P76 Use of delafloxacin for ciprofloxacin-resistant Pseudomonas aeruginosa foot osteomyelitis: a case report
- Difficult airway: are we ever truly prepared?
- In vitro activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan